导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 10.23% | 319/1050 |
| 近一周 | -0.67% | 389/1104 |
| 近一月 | -2.39% | 418/1103 |
| 近一季 | -6.22% | 532/1092 |
| 近半年 | 1.12% | 414/1070 |
| 近一年 | 16.21% | 292/1018 |
| 近两年 | 83.90% | 286/926 |
| 近三年 | 48.90% | 274/834 |
| 成立以来 | 139.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.44% 302/1070 |
21.48% 371/1101 |
- - |
- - |
| 2025 | 32.43% 434/1065 |
2.91% 550/1014 |
2.27% 484/1038 |
22.82% 512/1050 |
2.44% 275/1065 |
| 2024 | 5.75% 402/1011 |
-3.28% 493/960 |
-4.15% 580/983 |
13.78% 321/991 |
0.25% 302/1011 |
| 2023 | -8.28% 281/952 |
4.05% 373/880 |
-4.54% 496/895 |
-4.45% 263/915 |
-3.36% 363/952 |
| 2022 | -16.84% 215/867 |
-8.57% 78/773 |
2.90% 633/806 |
-8.79% 186/845 |
-3.09% 581/867 |
| 2021 | 21.06% 152/740 |
4.20% 60/580 |
9.96% 356/659 |
7.92% 86/704 |
-2.10% 515/740 |
| 2020 | 28.59% 356/554 |
-6.75% 334/419 |
17.72% 319/466 |
13.60% 168/517 |
3.12% 466/554 |
| 2019 | 24.90% 311/410 |
32.54% 246/1149 |
-8.46% 931/1231 |
-1.06% 356/390 |
4.05% 360/410 |
| 2018 | -29.91% 210/349 |
- - |
- - |
- - |
-12.88% 714/1080 |
| 2017 | 11.87% 125/285 |
- - |
- - |
- - |
- - |
| 2016 | -2.26% 35/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城量化精选股票 VS. 东吴新产业精选股票A(580008) |